Tag:

vaccines

Latest Headlines

Latest Headlines

Post-Novartis deal, GSK's top dog in vaccines, consumer health. Now what?

GlaxoSmithKline and Novartis have finally closed the multibillion-dollar asset swap that's sending GSK's oncology portfolio to Switzerland in exchange for most of the latter's vaccines unit. Now, all eyes will be on the British pharma giant, who industry watchers agree has more to prove after exiting the fast-growing cancer field.

Indonesia turns to Bio Farma to ramp up vaccines output as health spending soars

Indonesia has long been active in providing vaccines to other developing countries, but now finds itself in a bind and turning to its state-owned and century-old pharmaceutical company, Bio Farma, to solve the nation's own growing need for vaccines.

Indian portion of GSK-Novartis swap approved by GSK board

The board of directors at GlaxoSmithKline voted to approve the last phase of a three-part deal with Novartis, transferring GSK's cancer drug portfolio to Novartis Healthcare Pvt, its Indian arm. Distribution rights were ceded in exchange for acquiring the Swiss-based company's vaccines portfolio.

Glaxo layoffs continue as 27 Montana vaccine workers get the ax

GlaxoSmithKline's job-chopping ax has struck Hamilton, MT, where 27 vaccine researchers will pack up this year. The pharma giant plans to centralize its R&D efforts in one location, but where that will be hasn't yet been decided, company spokeswoman Melinda Stubbee told local paper  Missoulian.

Pet owners jump on antivaccine bandwagon, ignoring veterinarians' advice

There's a new health threat on the horizon: pet parents who are choosing not to vaccinate their dogs. The rabies vaccine is required by law, but vaccines against a host of other illnesses that endanger pets, such as distemper, are not, and therein lies the problem.

Soap bubbles make simple, inexpensive delivery vehicles for drugs, vaccines

Researchers at the University of Maryland have taken to using soap bubbles as vehicles for drugs and vaccines. The biomolecule-tagged spheres have been shown to be cost-effective and able to work with a broad spectrum of therapeutics, the scientists say.

New study clears Merck's blockbuster Gardasil of MS risk

Good news for Merck: According to a new study, its cash cow vaccine, HPV-blocker Gardasil, isn't linked to an increased risk of multiple sclerosis--or any other similar CNS diseases, for that matter.

With Swiss pickup, Pfizer adds CMV candidate to growing vaccines unit

After 2014's growth spurt, Pfizer's vaccines unit is not done expanding. The pharma giant has grabbed privately held Swiss company Redvax for an undisclosed sum, adding a preclinical human cytomegalovirus (CMV) vaccine candidate and a tech platform and IP related to a second, undisclosed vaccine program.

UPDATED: Novartis flu vaccine under the lens as Italy probes 13 deaths

Italy's drug regulator has a growing investigation on its hands, and Novartis is in the middle of it. The number of people who have died in the country after receiving one of the Swiss pharma giant's flu vaccines has risen by 10 just days after Italy issued a partial ban on the product.

Merck in talks with NewLink to scale up Ebola vaccine production: Bloomberg

Merck may soon be the next Big Pharma to step into the Ebola vaccine arena.